Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Lectin‐like oxidized low density lipoprotein receptor‐1 (LOX‐1) serves as an endothelial receptor for advanced glycation end products (AGE)
2002
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells
2005
The role of FLT3 in haematopoietic malignancies
2003
Generation of Human Melanocytes from Induced Pluripotent Stem Cells
2011 StandoutNobel
Advanced glycation and endothelial functions: A link towards vascular complications in diabetes
2004
Advanced Glycation End Products-Induced Gene Expression of Scavenger Receptors in Cultured Human Monocyte-Derived Macrophages
2000
Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
2010
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
1999
The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane Domain
2004
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Cytogenetics in acute leukemia
2003
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
Beneficial effects of α-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress
2001
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
2010
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB
1999
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
2001
Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats
2002
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
The Cancer Genome Atlas Pan-Cancer analysis project
2013 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
Micromanaging aging with miRNAs
2011
Direct conversion of human fibroblasts to multilineage blood progenitors
2010 Nature
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis
2004
Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells
2004
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
2009
MDR1 haplotypes significantly minimize intracellular uptake and transcellular P‐gp substrate transport in recombinant LLC‐PK1 cells
2006
Stem cell gene expression programs influence clinical outcome in human leukemia
2011
Collaboration of 3D context and extracellular matrix in the development of glioma stemness in a 3D model
2015
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
2010
Macrophage Responses to Hypoxia
2005
Diabetes and Atherosclerosis
2002 Standout
The Role of Oxidative Stress in Diabetic Complications
2005
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death
2012
Molecular genetics in acute myeloid leukemia
2010
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Diabetes and advanced glycation endproducts
2002
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Origin and physiological roles of inflammation
2008 StandoutNature
Molecular Genetic Pathways as Therapeutic Targets in Acute Myeloid Leukemia
2008
Acute Myeloid Leukemia (AML) with Erythroid Predominance Exhibits Clinical and Molecular Characteristics that Differ from Other Types of AML
2012
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
2008
AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
1998
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
The Hallmarks of Aging
2013 Standout
Idiopathic pulmonary fibrosis
2011 Standout
High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expression
1999
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The role of oxidative stress and NF‐κB activation in late diabetic complications
1999
Angiogenesis as a therapeutic target
2005 StandoutNature
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
2010
Diabetes Enhances Lectin-like Oxidized LDL Receptor-1 (LOX-1) Expression in the Vascular Endothelium: Possible Role of LOX-1 Ligand and AGE
2001
The cancer genome
2009 StandoutNature
Functional Characterization of FLT3 Receptor Signaling Deregulation in Acute Myeloid Leukemia by Single Cell Network Profiling (SCNP)
2010
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Acute Myeloid Leukemia
2015 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Advanced Glycation End Products
2006 Standout
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features
2006
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
2008
Negative consequences of glycation
2000
RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis
2010
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
2009
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Inflammation and Atherosclerosis
2002 Standout
Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system
2009
The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society
2001
Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells
2012 StandoutNobel
Oxidative Stress as a Regulator of Gene Expression in the Vasculature
1999
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction
2010
The Chemistry and Biochemistry of Vanadium and the Biological Activities Exerted by Vanadium Compounds
2004 Standout
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
RUNX1Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
2011
How I treat refractory and early relapsed acute myeloid leukemia
2015
The prognostic and functional role of microRNAs in acute myeloid leukemia
2010
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
1999 Standout
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)
2010
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
2003
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin
2004
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
2009
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells.
2000
Management of Acute Myelogenous Leukemia in the Elderly
2003
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Free Radicals in the Physiological Control of Cell Function
2002 Standout
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
2010
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond
2014
Acute Hyperglycemia Causes Intracellular Formation of CML and Activation of ras, p42/44 MAPK, and Nuclear Factor κB in PBMCs
2003
New Insights into the Pathophysiology of Chronic Myeloid Leukemia and Imatinib Resistance
2006
Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology
2009
Works of Thomas Illmer being referenced
Mutations in ras proto‐oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia
2001
Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia
2003
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
2008
The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia
2009
The expression of macrophage migration inhibitory factor 1α (MIF 1α) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability
2004
FLT3 Kinase Inhibitors in the Management of Acute Myeloid Leukemia
2007
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate
2004
Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome
2000
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia
2011
Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission
2005
Influence of Enzyme-Inducing Antiepileptic Drugs on Trough Level of Imatinib in Glioblastoma Patients
2008
Identification of acute myeloid leukaemia associated microRNA expression patterns
2007
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
2006
MicroRNA29a regulates the expression of the nuclear oncogene Ski
2011
The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
2001
Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid Leukemia
2008
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
2002
Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells
1997
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
2002
Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE
1997